z-logo
open-access-imgOpen Access
Novel Role of Lck in Leptin-Induced Inflammation and Implications for Renal Aging
Author(s) -
SungHoon Kim,
June Whoun Park,
Hyoung Oh Jeong,
Bonggi Lee,
Ki Wung Chung,
Yujeong Lee,
Hee Jin Jung,
Min Kyung Hyun,
A Kyoung Lee,
Byeong Moo Kim,
Byung Pal Yu,
Hae Young Chung
Publication year - 2019
Publication title -
aging and disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.808
H-Index - 54
ISSN - 2152-5250
DOI - 10.14336/ad.2019.0218
Subject(s) - leptin , inflammation , leptin receptor , medicine , proinflammatory cytokine , tyrosine kinase , gene knockdown , stat3 , endocrinology , cancer research , signal transduction , microbiology and biotechnology , biology , receptor , obesity , cell culture , genetics
Aging is associated with increased fat mass and elevated serum leptin levels (hyperleptinemia), causing proinflammation in the kidneys where it plays a primary role in the removal of endogenous leptin from the circulation. Lymphocyte-specific kinase (Lck) is a positive regulator of inflammatory signaling and a potential treatment target for age-related diseases, but its role in leptin signaling is unknown. Here, we investigated how Lck influences hyperleptinemia-induced inflammation in kidney tissues from 6- and 21-month-old rats. Results indicate that Lck expression and activation increased significantly in aged rat kidneys, especially at renal tubules. Furthermore, we identified interactions between Lck and short leptin-receptor isoforms, suggesting that Lck is a protein tyrosine kinase regulating leptin signaling. We further investigated whether increased Lck expression in renal tubular epithelial cells and macrophage infiltration are associated with leptin-induced inflammation. We then demonstrated that leptin activates Lck and proinflammatory transcription factors (STAT3 and NF-κB), while Lck knockdown modulates the expression of both transcription factors. Collectively, these data implicate that Lck leads to development of leptin-induced renal inflammation during aging. Inhibition of this protein tyrosine kinase may therefore be an appropriate therapeutic option for protection against age-related hyperleptinemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom